ALNYLAM PHARMACEUTICALS, INC. (ALNY) Gross profit 2017–2025
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual gross profit history from SEC filings — each fiscal year as reported.
$3.0BFY2025 · since FY2017: $89.9M → $3.0B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.0B | +56.4% |
| FY2024 | $1.9B | +24.5% |
| FY2023 | $1.6B | +73.9% |
| FY2022 | $897.2M | +23.0% |
| FY2021 | $729.3M | +74.2% |
| FY2020 | $418.7M | +115.0% |
| FY2019 | $194.7M | +166.3% |
| FY2018 | $73.1M | -18.7% |
| FY2017 | $89.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice